Calliditas Therapeutics US Inc.
$2.0M 12,051 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Biohaven Pharmaceutical Holding Company Ltd.
Biohaven Pharmaceutical Holding Company Ltd. reported $1,993,393.87 across General Payments, Research, and Ownership to 0 physicians and teaching hospitals across 2,430 transactions.
- $2.0M Top quartile payer
- All-tracks total
- 2,430 Top quartile volume
- Transactions
- 0 —
- Recipients
- −$13.4M
- General Payments vs PY2022
Biohaven Pharmaceutical Holding Company Ltd. reported $1,993,393.87 across all CMS Open Payments tracks (General + Research + Ownership) to 0 physicians and teaching hospitals in Program Year 2024 - ranking #449 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total), averaging $0.00 per recipient.
Biohaven Pharmaceutical Holding Company Ltd.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
28/100
Total payments
F
28/100
Transaction volume
F
28/100
Physician reach and Payment type diversity not applicable for Biohaven Pharmaceutical Holding Company Ltd. - no recorded activity on that dimension; its weight was redistributed to the applicable dimensions above.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer biohaven-pharmaceutical-holding-company-ltd Biohaven Pharmaceutical Holding Company Ltd.
$2.0M · #449/1,925 · 0.0% industry · PY2024
- TOT $2.0M
- RANK #449
- SHARE 0.0%
- TXN 2,430
- RCP 0
- CAT 0
- GEN n/a
- ΔGEN −$13.4M
- PY 2024
Volume peers
Nearest volume peer: Calliditas Therapeutics US Inc. ($2.0M)
Biohaven Pharmaceutical Holding Company Ltd. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2022 to PY2023
Biohaven Pharmaceutical Holding Company Ltd.'s CMS-reported General Payments decreased by $13.4M (−99.9%) from PY2022 to PY2023.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.PY2023: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.PY2024: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2022 vs PY2023
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2022
- $13,396,313.09
- PY2023
- $9,275.00
What the Data Shows for Biohaven Pharmaceutical Holding Company Ltd.
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Biohaven Pharmaceutical Holding Company Ltd. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
The 0-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). Payments are distributed across multiple categories without a dominant single type.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Biohaven Pharmaceutical Holding Company Ltd..
Showing 6 of 1,924 companies with CMS-reported payment data.
Shape Memory Medical Inc.
$2.0M 246 recipients
Compare payment profiles
Roche Diagnostics Corporation
$2.0M 900 recipients
Compare payment profiles
Immunocore Limited
$2.0M 1,028 recipients
Compare payment profiles
Omnia Medical, LLC
$2.0M 110 recipients
Compare payment profiles
Ferring Pharmaceuticals Inc.
$2.0M 21,199 recipients
Compare payment profiles
Put this to use
Biohaven Pharmaceutical Holding Company Ltd. ranks #449 of 1,925 by all-tracks total payments.
- See where Biohaven Pharmaceutical Holding Company Ltd. sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare payment categories across every manufacturer. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.